The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about how gene therapies will be regulated under new FDA leadership.

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

Beam Therapeutics shows promising BEACON trial results in SCD, backed by strong cash reserves and pipeline momentum. See why ...

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

And other biotech news brought to you by The Readout.

Verve's top drug, Verve-102, is designed to target a gene called PCSK9, which is associated with heart health and cholesterol levels.

The NSW government has announced an investment of A$20.7m ($13.39m) aimed at providing access to life-changing therapies.

"Comprehensive Review Highlights Market Growth, Innovation, and Investment Trends Driving the Future of Cell and Gene Therapy Tools, Biomanufacturing, and Gene Synthesis" BOSTON, June 20 ...

The Food and Drug Administration (FDA) announced a new crackdown Wednesday on the flow of American DNA to labs in ...